Jagsonpal Pharmaceuticals Quarterly Results

Pros & Cons

POSITIVES

No data available

NEGATIVES

Insufficient data to determine revenue trends or profitability.
Lack of operating profit figures limits analysis on operational efficiency.
Absence of historical context prevents insights on growth or market performance.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	57.83	47.23	43.49	61.44	74.69	74.03	58.56	75.61
Expenses	49.46	43.84	40.82	51.20	58.41	58.19	49.85	61.40
Operating Profit	8.36	3.40	2.67	10.24	16.28	15.83	8.71	14.21
Other Income	2.27	2.52	2.49	1.44	1.65	2.32	2.77	2.83
Interest	0.22	0.23	0.22	0.21	0.23	0.26	0.26	0.25
Depreciation	0.45	0.41	0.40	1.07	2.34	2.41	2.31	2.35
Profit Before Tax	9.96	5.28	4.54	7.11	15.37	38.67	8.71	14.43
Tax	2.49	1.32	0.99	1.78	3.91	6.68	2.13	3.64
Net Profit	7.47	3.96	3.55	5.33	11.46	31.99	6.58	10.79
Eps in Rs	2.84	1.48	1.31	1.94	4.29	4.74	0.98	1.60